LivingGLP1
Study S002509

Glycemia in Diabetic Elders Trial

Registration

Registration
NCT02029846
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
SINGLE
Status
TERMINATED
Enrollment
2
Start
2013-04
Primary completion
2017-02
Lead sponsor
Johns Hopkins University
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:Standard Treatment; DRUG:Incretin-Based Treatment
Results posted
TRUE

Registered primary outcomes

  • Time to Achieve Glycemic Target (HbA1c <7.5%). [6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.